Fiscal Year: January - December
Colgate-Palmolive Company (CL), listed on the NYSE, has a market capitalization of $68.31B. As of Apr 04, 2026, the stock is trading at $85.14 per share@else an unavailable price , offering investors a clear view of its current market value. Colgate-Palmolive Company is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 32.37, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. Colgate-Palmolive Company also offers a dividend yield of 2.44%, making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that Colgate-Palmolive Company (CL) may be overvalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for Colgate-Palmolive Company is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for Colgate-Palmolive Company, Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for Colgate-Palmolive Company is 18.8, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, Colgate-Palmolive Company (CL) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether Colgate-Palmolive Company (CL) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be overvalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of Colgate-Palmolive Company (CL) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of Colgate-Palmolive Company. To access the full SS Score, consider upgrading your subscription.
Colgate-Palmolive Company is a significant player in the industry sector, with a market capitalization of $68.31B and a competitive P/E ratio of 32.37. Investors should compare these metrics with industry peers to gauge whether Colgate-Palmolive Company is outperforming or underperforming within its sector.
Colgate-Palmolive expects to drive growth in North America this year, in part with new versions of products in oral and skin care.
A federal judge on Friday said Colgate-Palmolive must face two lawsuits claiming its packaging for mouth rinse misleads parents into believing children under 6 can use the products safely. The judge...
Dividend Aristocrats, tracked via NOBL, outperformed SPY YTD despite a sharp March pullback, with 44 Aristocrats beating SPY and 17 posting double-digit gains. Momentum, valuation (via dividend yield ...
The Dividend Kings outperformed SPY year-to-date, up 2.06% versus SPY's 3.06% loss, despite a March pullback. Seventeen Dividend Kings have double-digit gains in 2026, with Gorman-Rupp and Archer-Dani...
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, March 13, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the ...
NEW YORK--(BUSINESS WIRE)--The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today announced an increase in the quarterly common stock cash dividend to $0.53 up from $0.52 per share. The i...
Colgate-Palmolive Company (CL) Presents at UBS Global Consumer and Retail Conference Transcript
Colgate-Palmolive (CL) is set to announce its 63rd consecutive annual dividend increase, with a predicted 2.9–4.8% boost to an annualized $2.14–$2.18. CL's recent restructuring has driven double-digit...
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) is up 9.39% YTD in 2026, decisively outperforming SPY's 1.08%. Dividend Aristocrats are regaining momentum after a weak 2025, with 55 outpacing SPY...
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chief Investor Relations Officer and EVP, M&A, John Faucher, will participate in a fireside chat at the UBS Global Consumer and Retail Conference...
Colgate-Palmolive Company (CL) Presents at Consumer Analyst Group of New York Conference 2026 Transcript
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chairman, President and CEO, Noel Wallace, and SVP, Global Growth and Innovation, Hill's Pet Nutrition, Caroline Chulick, will present on Friday,...
Colgate-Palmolive's high returns in recent months are a direct result of the extremely negative investor sentiment in 2025. Although the stock now trades much closer to its fair value, margin improvem...
Colgate-Palmolive remains a Buy as it enters its next 5-year plan, leveraging strong brands and resilient financials. Q4 earnings beat expectations, with record cash flow from operations and robust pe...
Colgate-Palmolive Company (NYSE: CL) posted better-than-expected fourth-quarter earnings on Friday.
Colgate-Palmolive Company (CL) Q4 2025 Earnings Call Transcript
Colgate-Palmolive stock was up on the back of strong quarterly earnings.
Colgate-Palmolive swung to a loss in the fourth quarter, hurt by a large charge tied to its struggling skin-health business, but sales climbed despite what the company says is a difficult environment.
Toothpaste maker Colgate-Palmolive forecast annual sales above Wall Street estimates on Friday, benefiting from steady demand for essential household staples in markets such as Latin America and Europ...
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL): Full Year Net sales and Organic sales* increased 1.4%, including a 0.7% negative impact from lower private label pet volume GAAP EPS dec...
Colgate-Palmolive Company (NYSE: CL) will release earnings results for its second quarter, before the opening bell on Friday, Jan. 30.
Dividend Kings underperformed SPY in 2025, averaging 4.91% total return versus SPY's 17.72%, though 14 Kings outperformed the index. 2026 began strongly for Dividend Kings, up 4.66% through January 23...
NEW YORK--(BUSINESS WIRE)-- #ColgatePalmolive--Today, Colgate-Palmolive announced a new multi-year collaboration with the WHO Foundation to support the World Health Organization's work on oral health....
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
| Year | FCF Estimate | % | # Analysts |
|---|---|---|---|
| 2025 | 3.42B | -3.55% | Est @-3.6% |
| 2026 | 3.29B | -3.69% | Analyst x4 |
| 2027 | 3.48B | 5.68% | Analyst x4 |
| 2028 | 3.80B | 9.02% | Analyst x2 |
| 2029 | 3.94B | 3.74% | Analyst x1 |
| 2030 | 4.10B | 4.17% | Analyst x1 |
| 2031 | 4.21B | 2.74% | Est @2.7% |
| 2032 | 4.33B | 2.69% | Est @2.7% |
| 2033 | 4.44B | 2.65% | Est @2.6% |
| 2034 | 4.55B | 2.44% | Est @2.4% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
| Year | FCF | Discount Factor | PV of Future FCF |
|---|---|---|---|
| 2023A | 3.04B | 1.00 | 3.04B |
| 2024A | 3.55B | 1.00 | 3.55B |
| 2025E | 3.42B | 1.08 | 3.18B |
| 2026E | 3.29B | 1.16 | 2.84B |
| 2027E | 3.48B | 1.25 | 2.79B |
| 2028E | 3.80B | 1.34 | 2.83B |
| 2029E | 3.94B | 1.44 | 2.73B |
| 2030E | 4.10B | 1.55 | 2.64B |
| 2031E | 4.21B | 1.67 | 2.52B |
| 2032E | 4.33B | 1.80 | 2.40B |
| 2033E | 4.44B | 1.94 | 2.29B |
| 2034E | 4.55B | 2.08 | 2.18B |
| Terminal | 91.04B | 2.08 | 43.67B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.
